,i #aaf? ,,congress #a/ ,session ,h4 ,r4 #behj ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,may #h1 #bjai,mr4 ,david ,p4 ,roe ( ,t5nessee 7= himself & ,mr4 ,suozzi7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce1 & 9 addition to ! ,committee on ! ,judici>y1 = a p]iod to be subsequ5tly det]m9$ by ! ,speak]1 9 ea* case = consid]ation ( su* provisions z fall )9 ! jurisdiction ( ! committee conc]n$ ,a ,,bill ,to am5d ! ,controll$ ,sub/ances ,act to deem drugs or o!r sub/ances t act z mu opioid receptor agoni/s to be 9 s*$ule ,i1 subject to exceptions = sub/ances int5d$ = legitimate m$ical or rese>* use1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,mod]niz+ ,drug ,en=cem5t ,act ( #bjai4 #b4 ,drugs or o!r sub/ances t act z mu opioid receptor agoni/s 7a7 ,def9itions ,p>agraph 7#ah7 ( section #ajb ( ! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #hjb7 is am5d$ to read z foll[s3 7#ah7 7,a7 ,! t]m opiateor opioid-- 7i7 means any drug or o!r sub/ance hav+ an addiction-=m+ or addiction-su/a9+ liability simil> to morph9e or be+ capable ( conv]sion into a drug hav+ su* addiction-=m+ or addiction-su/a9+ liability2 & 7ii7 includes any drug or o!r sub/ance t acts z a mu opioid receptor agoni/4 7,b7 ,! t]m mu opioid receptor is a molecule t :5 b\nd to1 & activat$ by1 a mu opioid receptor agoni/ w\ld result 9 analgesia1 euphoria1 addiction1 or respiratory depression 9 ! c5tral n]v\s sy/em4 7,c7 ,! t]m mu opioid receptor agoni/ is a sub/ance t :5 b\nd to1 & int]act+ )1 ! mu opioid receptor1 activates ! receptor to result 9 analgesia1 euphoria1 addiction1 or respiratory depression4 4 7b7 ,s*$ul+ ,section #bja ( ! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #haa7 is am5d$ by add+ at ! end ! foll[+3 7k7 ,mu opioid receptor agoni/s 7#a7 ,9 g5]al ,effective z ( ! date ( enactm5t ( ! ,mod]niz+ ,drug ,en=cem5t ,act ( #bjai1 s*$ule ,i "u section #bjb is deem$ to include1 unless specifically exempt$ or unless li/$ 9 ano!r s*$ule1 any *emical sub/ances1 includ+ _! salts1 isom]s1 & salts ( isom]s :5ev] ! exi/5ce ( su* salts1 isom]s1 & salts ( isom]s is possible1 t act z mu opioid receptor agoni/s1 & any mat]ial1 comp\nd1 mixture1 or prep>ation t conta9s any quantity ( su* sub/ances4 7#b7 ,exceptions ,a *emical sub/ance is exempt f inclusion 9 s*$ule ,i by op]ation ( p>agraph 7#a7-- 7,a7 if ! sub/ance is ! subject ( an approv$ application submitt$ "u subsection 7b7 or 7j7 ( section #eje ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act2 7,b7 to ! ext5t ! sub/ance is exempt f ! provisions ( section #eje ( su* ,act relat+ to new drugs because-- 7i7 ! sub/ance is int5d$ solely = inve/igational use z describ$ 9 section #eje7;i7 ( su* ,act2 & 7ii7 ! sub/ance is be+ us$ exclusively = purposes ( a cl9ical trial t is ! subject ( an effective inve/igational new drug application2 or 7,c7 to ! ext5t ! sub/ance is ! subject ( a noncl9ical /udy by rese>*]s qualifi$ by sci5tific tra9+ to inve/igate ! safety & effectiv5ess ( drugs4 7#c7 ,li/+ ,n lat] ?an #ahj days aft] ! date ( enactm5t ( ! ,mod]niz+ ,drug ,en=cem5t ,act ( #bjai1 ! ,attorney ,g5]al %all update s*$ule ,i 9 accordance ) p>agraph 7#a74 ,! ,attorney ,g5]al may li/ sub/ances 9 s*$ule ,i pursuant to p>agraph 7#a7 )\t reg>d to ! process & consid]ations t are o!rwise applicable "u ?is section = add+1 remov+1 or transf]r+ controll$ sub/ances to1 f1 or among ! s*$ules "u section #bjb4 4